Vital Therapies aims even lower with $12-per-share IPO | MassDevice.com On Call

Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per share.

MASSDEVICE ON CALL — California biotherapeutics company Vital Therapies dropped its per-share price even lower, opening today at $12 per share in the hopes of raising $54 million. Shares are slated to open today on the Nasdaq market under the symbol "VTL."

Vital Therapies

News Well, Biotech , Initial Public Offering (IPO), Regenerative Medicine, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1hT8299